期刊名称：CLINICAL JOURNAL OF SPORT MEDICINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Clinical Journal of Sport Medicine presents expert clinical guidance and ongoing research activities in the diagnosis, treatment, and rehabilitation of sport-and-exercise related injuries. Articles are rigorously peer-reviewed by an outstanding international editorial board and cover timely topics in a wide variety of specialties including orthopedics, pulmonary medicine radiology, and rehabilitation.
Instructions to Authors
Scope
The Clinical Journal of Sport Medicine is an international, refereed journal published for clinicians with a primary interest in sport medicine practice. The Journal publishes original research and reviews covering diagnostics, therapeutics, and rehabilitation in healthy and physically challenged individuals of all ages and levels of sport and exercise participation.
Preparation of Manuscript
Original manuscripts, i.e., those that have not been published elsewhere except in abstract form, will be accepted from all countries and subject to peer review by the Editors and Editorial Board. The Clinical Journal of Sport Medicine invites articles for submission from the areas of: 1) diagnosis, treatment, and rehabilitation of sport and sport-related injuries, 2) medical illnesses induced by or exacerbated by exercise, 3) the relationship between exercise and health, and the exercise prescription, and 4) the medical care of physically active individuals.
Submission Categories
Articles are invited from the following categories: Original Research: clinical research and basic science articles that are clinically relevant; Brief Reports: clinical studies that are preliminary or limited in scope but with important findings to report; Case Reports: Reports of clinical observations that have been carefully documented and are particularly instructive.
Additional manuscripts may be submitted, after consulting with the Editor-in-Chief, in the following categories: Practical Management Manuscripts: focused, treatment-oriented reports from the perspective of the expert clinician; Lead Editorials: short syntheses of data and current thought on topical issues in the field of sport medicine; Critical Reviews: concise, in-depth, and well referenced articles that use the principles of critical appraisal (evidence-based medicine); Position Statements: succinct but comprehensive documents typically prepared by a recognized society for the purpose of providing clinical guidelines in important areas of sport medicine.
Please review specific submission category sections for detailed submission information. Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
1) Original Research
Authors are encouraged to submit articles in clinical research or basic science that are clinically relevant. For full-length research articles, organize the manuscript in the following sequence: Structured Abstract and Key Words, Introduction, Methods (subjects, procedures, outcome measures, analysis, etc.), Ethical Considerations, Results, Discussion, Acknowledgment, References, Tables, and Figure Legends. A structured abstract must be included with original research manuscripts (see Instructions for Structured Abstracts for detailed information).
2) Brief Reports
Brief Reports are considered for clinical studies that are preliminary or limited in scope but with important findings to report. The manuscript should have sections similar to Original Research manuscripts and the structured abstract should be brief (200 word limit). The manuscript itself should be limited to 1,000 words, excluding tables and figures. A maximum of 10 references will be accepted.
3) Case Reports
Case Reports considered for publication must meet the following criteria. They must: a) report a new syndrome, injury, or medical condition; b) report a new test or diagnostic technique or method; or c) draw attention to important clinical complications or problems associated with a common condition.
Specific case study criteria must be addressed: a) include at least one and a maximum of two figures; b) a structured abstract is not required; c) a maximum of 10 references will be accepted; d) the subheadings to be used are Introduction (one or two sentences), Case Report(s), and Discussion; e) the total length of the manuscript must not exceed two typeset pages (or approximately six typed, double-spaced manuscript pages), and the Editors reserve the right to shorten a manuscript to fit the space requirements. Generally speaking, two figures plus references will limit the maximum text to approximately 1,000 words.
4) Practical Management
Practical Management Manuscripts may be submitted only after consulting with the Editor-in-Chief. Practical Management manuscripts address a focused clinical issue from the perspective of the expert clinician. Manuscripts must be treatment oriented, with limited references and a maximum of two figures. Each practical management article should include a table that summarizes the recommendations in the manuscript. Headings in the table should be identical to those used in the manuscript. Under each heading, the treatment/management must be listed in order of priority (if applicable), or in terms of most to least commonly used. If authors are suggesting a new treatment or one that was not previously well accepted, this should be asterisked and qualified. The order of the items in the table should parallel the order of items in the article for consistency.
5) Lead Editorials
Lead Editorials may be submitted only after consulting with the Editor-in-Chief. Lead Editorials provide a forum to discuss critically important areas of interest that may benefit both clinicians and researchers. Editorials may reflect comment or criticism stimulated by articles appearing in the body of the journal, or provide perspectives and viewpoints on contemporary and controversial matters of distinct interest to the sport medicine practitioner and relevant to the world of sport, medicine and society at large. Editorials should be prepared with prose style and offer substantiated opinion. An editorial should not offer new, previously unpublished data, although authors may refer to data that has been published in abstract form. Specific sport medicine examples may be added to editorials to facilitate understanding.
6) Critical Reviews
Critical Reviews may be submitted only after consulting with the Editor-in-Chief. Purpose: The purpose of the Critical Reviews section is to increase the clinically relevant content of the Journal by publishing review papers that address difficult or controversial clinical topics of current interest to the sport medicine practitioner. The most unique aspect of this feature is that each article will be written or peer reviewed by both content and methodological experts, ensuring appropriate interpretation of existing studies. The technique of critical appraisal will filter, synthesize, and interpret information on a specific topic so that readers can be assured of reading accurate summaries of data from the literature on the topics most important to their clinical practice. Background: Although other journals in the area of exercise science and sport medicine actively solicit and publish topical reviews, the articles are of varying degrees of quality and depth. Moreover, many reviews are cumbersome and wordy, limiting their usefulness to the busy clinician. Furthermore, they often fall short of synthesizing available evidence on the topic of concern; rather they report (sometimes re-report) information gleaned from previous work. Because the typical clinical reader is not experienced in the evaluation of study design, they cannot fully assess the validity of the authors' conclusions.
Since the usefulness of a published report is related to the validity of the conclusions, as well as their relevance, both must be considered when preparing a review article. A standardized approach is needed to scrutinize both of these issues in preparing a review article and then effectively and efficiently communicate critical information necessary for practitioners faced with difficult or controversial clinical decisions. Enough basic science should be included in each Critical Review to provide a pathophysiological background for the question being posed. The Critical Review section of the Journal is designed to meet this need by applying strict methodologic criteria according to the established principles of evidence-based medicine to the review of specific topics. The findings will be published using a structured format that includes clinical commentary. In other words, this feature will function as a filtering process that serves as quality control by looking at both the process by which the original data was collected and analyzed and the relevance of the results themselves. Approach: The development and editorial process for the Critical Review section is the responsibility of the Editor-in-Chief, two Senior Associate Editors, and a large number of Associate Editors. Our goal is 2--3 articles per issue.
General Guidelines: 1) Develop a question that is clinically relevant, tightly focused, and will help the clinician with a patient in his or her office. This may be a question related to diagnosis, treatment, prognosis, etc. Authors should not attempt to review an entire clinical problem from A to Z. In situations where the literature is inadequate to render a clean decision regarding management, the clinical interpretation section of the paper needs to be particularly well crafted. 2) Read the sample articles listed in these Instructions. 3) Audience: practicing physicians. The article should be based on a synthesis of available information so that necessary points can be distilled. The paper should not discuss articles one at a time but should discuss concepts or categories of information and include the relevant articles under each category. The papers aspire to the highest quality standard in their writing style, grammar, accuracy, and literature synthesis. 4) The manuscripts will go through a peer-review process as any other paper submitted to the Journal. Occasionally, recruited manuscripts are not acceptable by peer-review standards. While this occurrence is uncommon, every attempt should be made to minimize this possibility though close interaction between the author and Editorial Board Member.
Format: The following format should be adhered to strictly to ensure uniformity between the articles. The Abstract should be written like a structured abstract for a scientific overview (see Instructions for Structured Abstracts). The Introduction is a brief statement of the problem stated as one or more questions, and the rationale or purpose of the manuscript. Subheadings should be used to provide background information, such as basic science, pathophysiology, etc., if they are critically important for the clinician to understand the topic. There must be a brief section detailing the Methods used to gather the papers being reviewed and the reasons for inclusion and exclusion of papers. A computerized literature search is required, and the key and MeSH words, time frame searched (years), number of hits generated by the search, and references from the bibliographies of the searched papers should be listed in table format. The Results section is the most critical part of the Critical Reviews manuscript; the results of the review are not only reported but also synthesized. It is suggested that papers reviewed be stratified by their study design into the following categories: Case Reports, Clinical Series (some kind of control, including historical controls), Cross-Sectional Studies, Case Control (retrospective) studies, Prospective and Historical Cohort, and Randomized Clinical Trials. There should be a table(s) in each review that lists the relevant details and results or outcomes of each study selected for review, stratified by type of study, or outcome (positive or negative). It is likely that the details for such a table will be different depending on the nature of the question being reviewed. However, some examples would include the following: Reference (including first author, year, and number), Participants (details including sample size, numbers of men/women, matched pairs, average age, tissue preparation, etc.), Antecedent (e.g., treatment condition, exposure variable, injury rate, etc.), Outcome (e.g., tensile strength, failure force, health quality of life, etc.), Key Findings (two or three sentences highlighting key findings), and Comments (to facilitate interpretation by the writer). The idea behind such a table is to provide a compact, useful reference for the reader without having to wade through paragraphs of text. Oftentimes a reviewer will comment in paragraph form about certain notable studies and not others. This prevents the reader from gleaning any real knowledge without reading the entire manuscript and also leaves the reader at the mercy of the reviewers' choices as to what information is presented. Using the above method, all relevant papers are included, stratified by study design, outcome, or both, so that the reader has more information on which to base a decision. The Results section can use subheadings based on study designs, results (positive or negative), the question(s) or parts of the question(s) being posed in the Introduction, animal versus clinical studies, etc. In interpreting the studies, weight should be placed on the better design studies. For example, a cross-sectional study with five patients would receive less weight than a randomized, controlled trial with adequate power. The author should choose the best approach to summarize the studies. This may or may not be a meta-analysis depending on the data. The Discussion section should not be an itemized reiteration of individual papers but rather a synthesis of information presented in the Results section. Subheadings should be used that reflect the major issues or different categories or outcomes and results. Often the literature fails to provide a clean answer to a clinical question. In this section the author may have to extrapolate the conclusions from suboptimal data (e.g., animal data, case series) to provide some guidance to the clinician. Any extrapolation and author bias (including anecdotal evidence) must be overtly stated so that readers with different viewpoints can make their own conclusions. The Conclusion section should be succinct and listed in point form. The Reference list should be complete and should follow AMA style (for examples of correctly styled references, see References in the Style and Formatting section of these Instructions). The writing style should be scientific without slang. It should give the clear impression that the material has been digested and interpreted rather than regurgitated. The maximum length for Structured Critical Reviews is 2,000-2,500 words, not including references, figures, and tables.
Sample Structured Clinical Reviews Articles:
1. Shrier I, Matheson GO, Kohl HW. Achilles tendonitis: are corticosteroid injections useful or harmful? Clin J Sport Med. 1996;6:245-250.
2. Garza D, Shrier I, Kohl HW, et al. The value of serum ferritin tests in athletes. Clin J Sport Med. 1997;7:46-53.
3. Lo IKY, Kirkley A, Nonweiler B, et al. Operative versus nonoperative treatment of acute Achilles tendon ruptures: a quantitative review. Clin J Sport Med. 1997;7:207-211.
Critical Review Structured Abstracts: Abstracts for Critical Review Manuscripts should have the following headings and information. Objective: State the primary objective of the review article. Data Sources: Describe the data sources that were searched, including dates, terms, and constraints. Study Selection: Identify the number of studies reviewed and the criteria used for their selection. Data Extraction: Summarize guidelines used for abstracting data and how they were applied. Data Synthesis: State the main results of the review and the methods used to obtain these results. Conclusions: State primary conclusions and their clinical applications, avoiding overgeneralization. Suggest areas for additional research if needed.
For more detailed information and examples of structured abstracts, please con-tact the Editor-in-Chief directly.
1. Hayes RB, Mulrow CD, Huth EJ, et al. More informative abstracts revisited. Ann Intern Med. 1990;113:69-76.
7) Position Statements
Position Statements may be submitted only after consulting with the Editor-in-Chief. These succinct but comprehensive documents are typically prepared by a recognized society for the purpose of providing clinical guidelines in important areas of sport medicine. A Position Statement should reflect both hard scientific evidence and the practical perspective of a controversial topic area.
Instructions for Structured AbstractsArticles containing original data concerning the course (prognosis), cause (etiology), diagnosis, treatment, prevention, or economic analysis of a clinical disorder or an intervention to improve the quality of health care must include a structured abstract of no longer than 250 words. The structured abstract should appear on the page following the title page, using the following headings and information.
Objective: State the main question or objective of the study and the major hypothesis tested, if any. Design: Describe the design of the study, indicating, as appropriate, use of randomization, blinding, criterion standards for diagnostic tests, temporal direction (retrospective or prospective), and so on. Setting: Indicate the study setting, including the level of clinical care (e.g., primary or tertiary, private practice or institutional). Patients or Participants: State selection procedures, entry criteria, and numbers of participants entering and finishing the study. Interventions: Describe essential features of any interventions, including their method and duration of administration. Main Outcome Measurements: The primary study outcome measures should be indicated as planned before data collection began. If the hypothesis being reported was formulated during or after data collection, this fact should be clearly stated. Results: Describe measurements that are not evident from the nature of the main results and indicate any blinding. Conclusions: State only those conclusions of the study that are directly supported by data, along with their clinical application (avoiding overgeneralization) or whether additional study is required before the information should be used in usual clinical settings. Please note:
- Equal emphasis must be given to positive and negative findings of equal scientific merit.
- Up to six key words should be included at the end of the structured abstract. In the case of research studies, a single statement summarizing the clinical relevance should be included.
Style and FormattingStyle: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in U.S.A.; city and country outside U.S.A.) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
Page format: Submitted manuscripts should have at least a 1-inch (2.5-cm) margin on all sides. The manuscript should be double spaced, including legends, footnotes, tables, and references.
Title page: Include on the title page: a) complete manuscript title; b) authors' full names, highest academic degrees, and affiliations; c) name and address for correspondence, including fax number, telephone number, and e-mail address; d) address for reprints if different from that of corresponding author; and e) sources of support that require acknowledgment.
Acknowledgments: Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use, unless it is a standard unit of measure, and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country).
References: The authors are responsible for the accuracy of the references. Key the references (double spaced) at the end of the manuscript. They should be cited in the text in the order of appearance. Cite unpublished data, such as papers submitted but not yet accepted for publication or personal communications, in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. Newcomer KL, Laskowski ER, Idank DM, et al. Corticosteroid injection in early treatment of lateral epicondylitis. Clin J Sport Med. 2001;11:214-222.
Book chapter
2. Claessens AL. Elite female gymnasts: a kinanthropometric over-view. In: Johnston FE, Eveleth P, Zemel B, eds. Human Growth in Context. London: Smith-Gordon and Co; 1999:273-280.
Entire book
3. Stewart JD, ed. Focal Peripheral Neuropathies. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
Software
4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
Online journal
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables at the end of the manuscript, or supply them together in a separate file. Cite tables consecutively in the text, and number them in that order. Key on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Figures: Cite figures consecutively in the text, and number them in the order in that they are discussed. If submitting the manuscript electronically, please see Digital Figures. If submitting the manuscript via post mail, please write the first author's last name, the figure number and figure part (1A, 1B, 1C), and an arrow to indicate the top edge of the figure on a label pasted to the back of each figure. Submit all artwork in triplicate in camera-ready form; illustrations should be glossy prints or high-quality, laser-printed illustrations. Photocopies are unacceptable. Lettering should be large enough that it will remain legible after figure reduction; typewritten or unprofessional lettering is unacceptable. Figure parts (A, B, C) may be left unlabeled (but clearly marked on back) for professional placement by the journal's printer.
Figure legends: Legends must be submitted for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Digital figures: Electronic art should be created/scanned and saved and submitted as either a TIFF (tagged image file format) or JPEG (Joint Photographic Expert Group) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs-radiographs, CT scans, and so on-and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. All electronic art must be accompanied by high-resolution laser prints of the images. Files can be submitted electronically (to cjsm@ucalgary.ca) as attachments or on a 3 1/2-inch high-density disk or a CD-ROM.
Electronic files (e-mail attachments or disk copies): Electronic files should be submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files. Do not use automatic numbering or footnotes for references. Manuscripts should be submitted in a single electronic file (i.e., structured abstract, manuscript, references, tables, and figures in one saved file). Photographs and art can be attached as a separate file. The Journal does not assume responsibility for errors in the conversion of customized software, newly released software, and special characters. Authors preparing manuscripts on Macintosh computers should not use the Fast Save option. Each submitted disk must be clearly labeled with the name of the author, item title, journal title, word processing program and version, and file name used. Figures should be saved as TIFF or JPEG files.
Ethical/Legal ConsiderationsA submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: All authors must sign a copy of the journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form and submit it with the original manuscript.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
Manuscript SubmissionSend the manuscript with an accompanying cover letter that includes the corresponding author's e-mail address and full mailing address as attachments via e-mail to cjsm@ucalgary.ca or send three paper copies of the manuscript, one disk copy, and a cover letter via post mail to Editor-in-Chief Willem Meeuwisse, MD, PhD, Clinical Journal of Sport Medicine, c/o Pamela Cameron, Managing Editor, University of Calgary, Sport Medicine Center, 2500 University Drive NW, Calgary, AB T2N 1N4, Canada. If you have any questions regarding manuscript submissions, please contact Pamela Cameron at cjsm@ucalgary.ca, (Tel) 403-220-8947, (Fax) 403-210-9393. Please see the checklist at the end of these Instructions before mailing manuscripts. Following your submission, the editorial office will acknowledge the receipt of your manuscript and will give you a manuscript number for reference.
Manuscript RevisionsManuscripts returned to authors for revisions must be resubmitted (with revisions) within two months to be considered for publication. Revised manuscript submission must include: a cover letter, the revised manuscript, and a letter itemizing, point by point, the response to each one of the suggestions/criticisms raised by the referees, highlighting the response and revisions made to the manuscript, or providing justifiable rebuttal.
Accepted ManuscriptsPage proofs and corrections: Corresponding authors will receive page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author via e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected pages to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to Journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with page proofs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106, with any questions.
Publisher's contact: Fax corrected page proofs, reprint order forms, and any other related materials to Production Editor, Clinical Journal of Sport Medicine, 717-632-8448 x 8219. Color proofs should be returned to Production Editor, Clinical Journal of Sport Medicine, The Sheridan Press, 450 Fame Avenue, Hanover, PA 17331.
Manuscript Checklist (before submission) To top of page
Please ensure that each of the following items has been included with your manuscript submission to CJSM:
- Three sets of clearly labeled figures
- Cover letter
- Title page
- Abstract (structured abstract mandatory for articles containing original data)
- References doubled spaced in AMA style
- Corresponding author designated (in cover letter and on title page)
- E-mail address of corresponding author included on cover letter and on title page
- Permission to reproduce copyrighted materials or signed patient consent forms
- Acknowledgments listed for grants and technical support
- Authorship Responsibility, Financial Disclosure, and Copyright Transfer form signed by each author
- Tables created using table software feature
- Manuscripts may be submitted either: a) via e-mail (as an attachment) to cjsm@ucalgary.ca, or b) via post mail (please include three paper copies and one disk copy in an extra-strength envelope)
Editorial Board
|
EDITOR-IN-CHIEF
Willem Meeuwisse, MD, PhD
University of Calgary
Sport Medicine Centre
2500 University Drive NW
Calgary, AB T2N 1N4 Canada
Tel: (403) 220-8563
Fax: (403) 220-9489
E-mail: cjsm@ucalgary.ca
|
Pamela Cameron
Managing Editor
University of Calgary
Sport Medicine Centre
2500 University Drive NW
Calgary, AB T2N IN4
Canada
Tel: (403) 220-8947
Fax: (403) 210-9393
E-mail: cjsm@ucalgary.ca |
| |
SENIOR ASSOCIATE EDITORS
|
| |
Mark E. Batt, MB, BChir
Nottingham, England
Tom Best, MD, PhD
Madison, Wisconsin, U.S.A.
Gunnar Brolinson, DO
Blacksburg, Virginia
Peter D. Brukner, MBBS
Melbourne, Victoria, Australia
Lawrence Hart, MD
Hamilton, Ontario, Canada
|
Harold W. Kohl III, PhD
Altanta, Georgia
Douglas B. McKeag, MD, MS
Indianapolis, Indiana, U.S.A.
Andrew Pipe, MD
Ottawa, Ontario, Canada
Ian Shrier, MD, PhD
Montreal, Quebec, Canada
Willem van Mechelen, MD, PhD
Amsterdam, The Netherlands
Stuart M. Weinstein, MD
Seattle, Washington, U.S.A. |
| |
ASSOCIATE EDITORS
|
| |
Annunziato Amendola, MD, FRCS(C)
Iowa City, Iowa
Michael Fredericson, MD
Palo Alto, California, U.S.A.
Peter Fricker, MBBS
Belconnen, ACT, Australia
James G. Garrick, MD
San Francisco, California, U.S.A.
Jeremiah C. Healey, MB, BS
London, England
Mark S. Juhn, DO
Seattle, Washington, U.S.A.
Pekka Kannus, MD
Tampere, Finland
|
W. Ben Kibler, MD
Lexington, Kentucky, U.S.A.
Caroline Macera, PhD
Atlanta, Georgia, U.S.A.
James G. Macintyre, MD
Salt Lake City, Utah, U.S.A.
Nicholas G. Mohtadi, MD
Calgary, Alberta, Canada
Aurelia Nattiv, MD
Los Angeles, California, U.S.A.
Timothy D. Noakes, MD
Constantia, South Africa
Robert Petrella, MD, PhD
London, Ontario, Canada |
| |
EDITORIAL BOARD
|
| |
Roald Bahr, MD, PhD
Oded Bar-Or, MD
Kim Bennell, PT
Dennis Caine, PhD
Priscilla Clarkson, PhD
Ken Crichton, MB, BS
Bryan English, MB, BChir, DO
William F. Feldner, DO
Barry Franklin, PhD
Norman Gledhill, PhD
Richard J. Hawkins, MD
John M. Henderson, DO
Beat Hintermann, MD
David Humphries, MB, BS
Barry Jordan, MD
Edward R. Laskowski, MD
Connie Lebrun, MD
Wade Lillegard, MD
Nicola Maffulli, MD
David J. Magee, PhD
|
Murray Maitland, PhD
Bob Malina, MD
Jenny McConnell, MSc
Bob McCormack, MD
Paul McCrory, MB, BS
Lyle Micheli, MD
Jonathan Myers, PhD
Scott F. Nadler, DO
Nicholas S. Peirce, MB, BS
Thomas A. Scandalis, DO
Roy J. Shephard, MD, PhD
Bryan Smith, MD, PhD
Ralph Strother, MD
Jeffrey Tanji, MD
Jack Taunton, MD
Preston Wiley, MD
Leonard Wilkerson, DO
Robert E. Windsor, MD
Ron Zernicke, PhD |
| |
FOUNDING EDITOR
Gordon O. Matheson, MD, PhD
EDITORIAL ASSOCIATE JOURNAL CLUB
Ann Lotter
Hamilton, Ontario, Canada
|
|
刊名字顺( Alphabetical List of Journals):
返回页首 